USC Norris Cancer Center
Obstetrics & Gynecology
Dr. Lynda D. Roman, MD
|
|
Give Review
Doctor Lynda D. Roman, MD works in the field of Obstetrics & Gynecology. She over the years received 2 awards: "Super Doctor" and "Fellow (FACOG)". Lynda D. Roman, MD is a published doctor. She published 83 publications, including: 'Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study.' Doctor Lynda D. Roman, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial Cancer.
- Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial Cancer.
- Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis.
- Timing of Intrauterine Manipulator Insertion During Minimally Invasive Surgical Staging and Results of Pelvic Cytology in Endometrial Cancer.
- Prediction of concurrent endometrial Carcinoma in women with endometrial hyperplasia.
- Effects of imiquimod on vulvar Paget's Disease: a systematic review of literature.
- Escalation of oncologic services at the end of life among patients with gynecologic Cancer at an urban, public hospital.
- Time interval between endometrial biopsy and surgical staging for type I endometrial Cancer: association between tumor characteristics and survival outcome.
- Survival outcome of stage I ovarian clear cell Carcinoma with lympho-vascular space invasion.
- Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors.
- Significance of Adenomyosis on Tumor Progression and Survival Outcome of Endometrial Cancer.
- Effect of lymphovascular space invasion on survival of stage I epithelial ovarian Cancer.
- Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian Carcinoma.
- Abdominal Aortic Resection and Y-Graft Placement to Achieve Complete Cytoreduction in Stage IIIc Ovarian Carcinoma.
- A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced Cancer of the ovary, peritoneum, and fallopian tube.
- Cervical conization of adenoCarcinoma in situ: A predicting model of residual disease.
- Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: An early glimpse into a challenging initiat...
- Endometrial echo complex thickness in PostMenopausal endometrial cancer.
- Predictive model of venous thromboembolism in endometrial Cancer.
- Successful extraction of cardiac-extending intravenous leiomyomatosis through gonadal vein.
- Significance of lymphovascular space invasion in epithelial ovarian Cancer.
- Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer.
- Significance of Perioperative Infection in Survival of Patients With Ovarian Cancer.
- [Characteristics of tumor growth in patients with locally-advanced gastric Cancer].
- Genome-scale screen for DNA methylation-based detection markers for ovarian Cancer.
- Overcoming platinum resistance in ovarian Carcinoma.
- Analysis of outcomes of microinvasive adenoCarcinoma of the uterine cervix by treatment type.
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.
- [Outcomes of surgical treatment for locally advanced gastric Cancer].
- [Palliative resection in esophageal Cancer].
- Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell Carcinoma of the cervix: a gynecologic oncology group study.
- Polymorphisms and clinical outcome in recurrent ovarian Cancer treated with cyclophosphamide and bevacizumab.
- Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian Cancer: a trial of the California, Chicago, and Princess Marg...
- A phase II study of Hsp-7 (SGN-00101) in women with high-grade Cervical intraepithelial neoplasia.
- Phase II clinical trial of docetaxel in refractory squamous cell Carcinoma of the cervix: a Gynecologic Oncology Group Study.
- Therapeutic vaccination for HPV induced Cervical cancers.
- Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian Cancer: potential predictive relationship with tumor HER2 activation st...
- Feasibility of laparoscopic extraperitoneal surgical staging for locally advanced cervical Carcinoma in a gynecologic oncology fellowship training program.
- Endometrial Cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes.
- Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous Cancer of the cervix.
- Pregnancy after radical Vaginal trachelectomy: maybe not such a risky undertaking after all.
- The impact of anti HPV vaccination on Cervical cancer incidence and HPV induced Cervical lesions: consequences for clinical management.
- Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant Ovarian tumors.
- Phase I clinical trial of topotecan and pegylated liposomal doxorubicin.
- Extraperitoneal laparoscopic lymph node staging: the University of Southern California experience.
- Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian Cancer.
- [Comparative clinical evaluation of the effectiveness of modified radical mastectomy and organ-preserving therapy in localized breast Cancer (pT1-2N0M0)].
- Detection of residual subclinical ovarian Carcinoma after completion of adjuvant chemotherapy.
- Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical Carcinoma.
- Treatment of patients with ovarian Carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome.
- The use of a Pelvic displacement prosthesis to exclude the small intestine from the radiation field following radical hysterectomy.
- [Long-term outcome of surgical treatment of patients with esophageal Cancer].
- A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade Cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.
- Phase II study of liposomal doxorubicin in advanced gynecologic Cancers.
- [Lymph node dissection in esophageal Cancer].
- A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell Carcinoma of the cervix.
- Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study.
- A phase II trial of CPT-11 in recurrent squamous Carcinoma of the cervix: a gynecologic oncology group study.
- Carcinoembryonic antigen in women with isolated Pelvic masses. Clinical utility?
- Small cystic Pelvic masses in older women: is surgical removal necessary?
- Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous Cancer of the cervix.
- Detection of ovarian Cancer cells: comparison of a telomerase assay and cytologic examination.
- Risk of residual invasive disease in women with microinvasive squamous Cancer in a conization specimen.
- Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin).
- Carboplatin as a radiation sensitizer in locally advanced Cervical cancer: a pilot study.
- Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic Cancer.
- Phase II study of liposomal doxorubicin in refractory ovarian Cancer: antitumor activity and toxicity modification by liposomal encapsulation.
- Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical Carcinoma.
- Preliminary analysis of the behavior of stage I Ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study.
- Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography.
- The role of endoCervical curettage at Cervical conization for high-grade dysplasia.
- Intraperitoneal 5-fluoro-2''-deoxyuridine (FUDR) and (S)-leucovorin for Disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study.
- The significance of positive margins in loop electrosurgical cone biopsies.
- Paclitaxel (Taxol) in heavily pretreated ovarian Cancer: antitumor activity and complications.
- Death from anaphylaxis to cisplatin: a case report.
- Cervical cancer in pregnancy: reporting on planned delay in therapy.
- Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive Cancer of the cervix.
- Dedifferentiated extraUterine adenosarcoma responsive to chemotherapy.
- Reasons for inappropriate simple hysterectomy in the presence of invasive Cancer of the cervix.
- High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial Cancer.
- Unsuspected invasive squamous cell Carcinoma of the vulva in young women.
- Primary adenoCarcinoma of the breast arising in the vulva.
Schools
McGill University Faculty Of Medicine
Procedures Preformed
- Colposcopy
- EndoCervical Curettage
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Gynecologic Cancer Screening
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Super Doctor
- Fellow (FACOG)
Education
-
University of Texas MD Anderson Cancer Center -
University of Massachusetts -
McGill University Faculty of Medicine
Hospital
-
Huntington Memorial Hospital -
Keck Hospital of USC
Drug Facts
| NPI NUMBER | 1386649713 | |
| NPPES Provider LastName | ROMAN | |
| NPPES Provider FirstName | LYNDA | |
| NPPES Provider ZIPCode | 911053154 | |
| NPPES Provider State | CA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 191.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 9.42 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386649713 |
| Last Name Of The Provider | ROMAN |
| First Name Of The Provider | LYNDA |
| View All |
Similar Doctors
|
|
Dr. Huyen Q. Pham, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Frances Y. Teng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles P. Morrow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah A. Yu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennie J. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle L. Yu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laila I. Muderspach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa M. Grier, MD
This Doctor is OpenDoctor Recommended.
|